339 related articles for article (PubMed ID: 33893508)
21. Effect of Helicobacter pylori eradication on metachronous recurrence after endoscopic resection of gastric neoplasm.
Bae SE; Jung HY; Kang J; Park YS; Baek S; Jung JH; Choi JY; Kim MY; Ahn JY; Choi KS; Kim DH; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
Am J Gastroenterol; 2014 Jan; 109(1):60-7. PubMed ID: 24343545
[TBL] [Abstract][Full Text] [Related]
22.
Ford AC; Yuan Y; Moayyedi P
Gut; 2020 Dec; 69(12):2113-2121. PubMed ID: 32205420
[TBL] [Abstract][Full Text] [Related]
23. Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis.
Kowada A; Asaka M
Helicobacter; 2021 Oct; 26(5):e12837. PubMed ID: 34278663
[TBL] [Abstract][Full Text] [Related]
24. Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study.
Kumar S; Metz DC; Ellenberg S; Kaplan DE; Goldberg DS
Gastroenterology; 2020 Feb; 158(3):527-536.e7. PubMed ID: 31654635
[TBL] [Abstract][Full Text] [Related]
25. Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases.
Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Yokota K; Oguma K
J Gastroenterol; 2007 Jan; 42 Suppl 17():21-7. PubMed ID: 17238021
[TBL] [Abstract][Full Text] [Related]
26. [The effect of H. pylori eradication against prevention of gastric cancer].
Mabe K; Kato M; Ono S; Asaka M; Sakamoto N
Nihon Rinsho; 2012 Oct; 70(10):1726-30. PubMed ID: 23198552
[TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori eradication as a preventive tool against gastric cancer.
Hamajima N; Goto Y; Nishio K; Tanaka D; Kawai S; Sakakibara H; Kondo T
Asian Pac J Cancer Prev; 2004; 5(3):246-52. PubMed ID: 15373702
[TBL] [Abstract][Full Text] [Related]
28. Eradication of Helicobacter pylori for primary gastric cancer and secondary gastric cancer after endoscopic mucosal resection.
Kato M; Asaka M; Ono S; Nakagawa M; Nakagawa S; Shimizu Y; Chuma M; Kawakami H; Komatsu Y; Hige S; Takeda H
J Gastroenterol; 2007 Jan; 42 Suppl 17():16-20. PubMed ID: 17238020
[TBL] [Abstract][Full Text] [Related]
29. Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection.
Kwon Y; Jeon S; Nam S; Shin I
Aliment Pharmacol Ther; 2017 Oct; 46(8):758-767. PubMed ID: 28799258
[TBL] [Abstract][Full Text] [Related]
30. Seventeen-year effects of eradicating Helicobacter pylori on the prevention of gastric cancer in patients with peptic ulcer; a prospective cohort study.
Take S; Mizuno M; Ishiki K; Hamada F; Yoshida T; Yokota K; Okada H; Yamamoto K
J Gastroenterol; 2015 Jun; 50(6):638-44. PubMed ID: 25351555
[TBL] [Abstract][Full Text] [Related]
31. Effects of eradicating Helicobacter pylori on metachronous gastric cancer prevention: A systematic review and meta-analysis.
Fan F; Wang Z; Li B; Zhang H
J Eval Clin Pract; 2020 Feb; 26(1):308-315. PubMed ID: 31141285
[TBL] [Abstract][Full Text] [Related]
32. Mass eradication of
Chiang TH; Chang WJ; Chen SL; Yen AM; Fann JC; Chiu SY; Chen YR; Chuang SL; Shieh CF; Liu CY; Chiu HM; Chiang H; Shun CT; Lin MW; Wu MS; Lin JT; Chan CC; Graham DY; Chen HH; Lee YC
Gut; 2021 Feb; 70(2):243-250. PubMed ID: 32792335
[TBL] [Abstract][Full Text] [Related]
33. Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial.
Choi JM; Kim SG; Choi J; Park JY; Oh S; Yang HJ; Lim JH; Im JP; Kim JS; Jung HC
Gastrointest Endosc; 2018 Sep; 88(3):475-485.e2. PubMed ID: 29800546
[TBL] [Abstract][Full Text] [Related]
34. Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan.
Tsuda M; Asaka M; Kato M; Matsushima R; Fujimori K; Akino K; Kikuchi S; Lin Y; Sakamoto N
Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28771894
[TBL] [Abstract][Full Text] [Related]
35. Helicobacter pylori status and risks of metachronous recurrence after endoscopic resection of early gastric cancer: a systematic review and meta-analysis.
Xiao S; Li S; Zhou L; Jiang W; Liu J
J Gastroenterol; 2019 Mar; 54(3):226-237. PubMed ID: 30251121
[TBL] [Abstract][Full Text] [Related]
36. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
37. Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: underlying biochemical and molecular events.
Kabir S
Helicobacter; 2009 Jun; 14(3):159-71. PubMed ID: 19702845
[TBL] [Abstract][Full Text] [Related]
38. Impact of the timing of Helicobacter pylori eradication on the risk of development of metachronous lesions after treatment of early gastric cancer: a population-based cohort study.
Kim HJ; Kim YJ; Seo SI; Shin WG; Park CH
Gastrointest Endosc; 2020 Sep; 92(3):613-622.e1. PubMed ID: 32473251
[TBL] [Abstract][Full Text] [Related]
39. Review article: the epidemiology and prevention of gastric cancer.
Fock KM
Aliment Pharmacol Ther; 2014 Aug; 40(3):250-60. PubMed ID: 24912650
[TBL] [Abstract][Full Text] [Related]
40.
Li L; Yu C
Biomed Res Int; 2019; 2019():9824964. PubMed ID: 31737682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
